Mark J. Foley - CEO, Director at Revance Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
RVNC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mark J. Foley - trading volume in the past year for Revance Therapeutics, Inc.

Holdings reported by Mark J. Foley for Revance Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Performance Stock Units 1.07M $7.99M $7.47 Jan 31, 2024 Direct Common Stock
Common Stock 996K $2.18M $2.18 Jun 30, 2024 Direct
Common Stock 111K $242K $2.18 Jun 30, 2024 Indirect

Transactions reported by Mark J. Foley for Revance Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.